|
|
||||
|
|
||||
|
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basic and Translational Investigations |
Department of Neurosurgery (D.K., M.M., Y.G., N.H., K.Y., T.Sh., S.N., T.Sa.) and Department of Neuropathology (S.O.S.), Graduate School of Medical Sciences, and Division of Genome Analysis, Research Center for Genetic Information, Medical Institute of Bioregulation (D.K., Y.G., Y.K., T.T., K.H.), Kyushu University, Fukuoka, Japan
Address correspondence to Kenshi Hayashi, Division of Genome Analysis, Research Center for Genetic Information, Medical Institute of Bioregulation, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan (khayashi{at}gen.kyushu-u.ac.jp).
We have employed a laser-capture microdissection technique and single-nucleotide polymorphism arrays to characterize genomic alterations associated with the development of glioblastoma multiforme (GBM). Combined analysis of loss of heterozygosity (LOH) and copy number revealed that more than half (56.3%) of the 254 identified LOH loci showed no copy-number alteration, indicating the presence of copy-number neutral LOH (cnLOH). Furthermore, we found a GBM case that showed cnLOH in 18 of the 22 autosomes. These results were confirmed by quantitative real-time PCR, microsatellite analysis, and fluorescence in situ hybridization. The high rate of cnLOH suggests that epigenetic abnormalities of many genes are involved in the development and progression of GBMs.
Key Words: copy-number alteration copy-number neutral LOH glioblastoma loss of heterozygosity single-nucleotide polymorphism array
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
|
|